Skip to Content
Merck
CN

D1163

DOTAP methosulfate

Reagent for stable and transient DNA/RNA transfections

Synonym(s):

N-(2,3-Dioleoyloxy-1-propyl)trimethylammonium methyl sulfate, Transfection reagent

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Empirical Formula (Hill Notation):
C43H83NO8S
CAS Number:
Molecular Weight:
774.19
UNSPSC Code:
12352200
PubChem Substance ID:
MDL number:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


grade

Molecular Biology

form

liquid (MES buffered saline)

usage

sufficient for 40 transfections (10 cm dishes)

concentration

1 mg/mL

color

clear to hazy colorless to faint yellow

storage temp.

2-8°C

SMILES string

[H]C(C[N+](C)(C)C)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.O=S([O-])(OC)=O

InChI

1S/C42H80NO4.CH4O4S/c1-6-8-10-12-14-16-18-20-22-24-26-28-30-32-34-36-41(44)46-39-40(38-43(3,4)5)47-42(45)37-35-33-31-29-27-25-23-21-19-17-15-13-11-9-7-2;1-5-6(2,3)4/h20-23,40H,6-19,24-39H2,1-5H3;1H3,(H,2,3,4)/q+1;/p-1/b22-20-,23-21-;

InChI key

RSMRWWHFJMENJH-LQDDAWAPSA-M

General description

DOTAP or N-(2, 3-Dioleoyloxy-1-propyl) trimethylammonium methyl sulfate is a cationic liposome-forming compound for transfection of DNA, RNA and other negatively charged molecules into eukaryotic cells.

Application

Cationic liposome-forming compound for transfection of DNA, RNA and other negatively charged molecules into eukaryotic cells. Mixing DOTAP with DNA results in spontaneously formed stable complexes that can be directly added to cell culture medium. These complexes fuse with the cell membrane and release DNA into the cytoplasm. The cells are transfected efficiently without cytotoxic effects. Use approximately 5-10 μg DOTAP per μg DNA and approximately 10-20 μg DOTAP per mL cell culture medium. The optimal working concentration and transfection time depends in part on the cell line used, and the type of material (RNA, DNA, protein) loaded.
Suitable for transient and stable transfection of DNA into cultured mammalian cells. Use approximately 5-10 μg DOTAP per μg DNA and approximately 10-20 μg DOTAP per mL cell culture medium. Protocol optimization within these guidelines provides very efficient transfection. The following cells have been successfully transfected using the DOTAP method:

A549
B6
BHK
BNL CL.2
C2
C6
Cardiomyocytes
CHO
COS-1
COS-7
Embryonic Fibroblasts (rat)
Embryonic stem cells (mouse)
Fibroblasts (primary human)
H225
Hepatocytes (primary rat)
HepG2
HEK293
HeLa
Hippocampal neurons (mouse and rat)
HMEC-1
Huh7
Jurkat
Lymphocytes (human peripheral blood)
M17
Macrophage (mouse)
MCF-7
MDA-MB-435
NIH3T3
Sf9
Smooth Muscle (rat aortic)
Spleen (mouse)
Vero
WI-38

Biochem/physiol Actions

A stable complex is formed when DOTAP is mixed with DNA in the absence of serum. The complexes are stable and can be directly added to the cell culture medium, where they fuse with the cell membrane, releasing the DNA into the cytoplasm. Note: complex formation is inhibited by serum, but once stable complexes have formed, the presence of serum is without consequence.

Features and Benefits

  • Up to 100x more efficient than calcium phosphate and DEAE transfection
  • Lower toxicity than calcium phosphate and DEAE based transfection
  • Compatible with both serum and serum-free transfection protocols
  • Compatible with in-vivo transfection protocols


Storage Class

12 - Non Combustible Liquids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



Lipid-Based Nanocarriers for RNA Delivery.
Xue HY
Current Pharmaceutical Design, 21(22), 3140-3147 (2015)
Murali Muniraju et al.
Journal of virology, 93(16) (2019-05-31)
Kaposi sarcoma-associated herpesvirus (KSHV) is an emerging pathogen and is the causative infectious agent of Kaposi sarcoma and two malignancies of B cell origin. To date, there is no licensed KSHV vaccine. Development of an effective vaccine against KSHV continues
Lea I Mikkola et al.
PLoS genetics, 15(7), e1008197-e1008197 (2019-07-20)
Canine hip dysplasia is a common, non-congenital, complex and hereditary disorder. It can inflict severe pain via secondary osteoarthritis and lead to euthanasia. An analogous disorder exists in humans. The genetic background of hip dysplasia in both species has remained